Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/26854
Title: | Reflux disease: The view of the internist. | Authors: | Hansky J. | Institution: | (Hansky) Gastroenterology Unit, Monash Medical Centre, Clayton, Vic., Australia (Hansky) Gastroenterology Unit, Monash Medical Centre, Victoria, 246 Clayton Road, Clayton, Vic. 3168, Australia | Issue Date: | 2-Nov-1996 | Copyright year: | 1996 | Publisher: | Taylor and Francis A.S. (P.O. Box 2562 Solli, Oslo 0202, Norway) Taylor and Francis A.S. |
Place of publication: | Norway | Publication information: | Scandinavian Journal of Gastroenterology, Supplement. 31 (220) (pp 63-65), 1996. Date of Publication: 1996. | Journal: | Scandinavian Journal of Gastroenterology, Supplement | Abstract: | Pathogenesis of GERD is mainly concerned with a defective antireflux barrier to gastric and duodenal contents. Transient lower oesophageal sphincter relaxation is thought to be the main mechanism by which reflux is permitted, but the mucosal exposure time to the refluxate, the nature of the refluxed material and oesophageal clearance are important mechanisms. The internist only sees the 'tip of the iceberg' as far as GERD is concerned, and generally these are severe resistant cases of GERD. In this group, endoscopy is mandatory to assessing degree of inflammation and treatment is generally with proton-pump inhibitors, which have made the therapy of GERD relatively easy. Although treatment is effective, problems relating to safety of long-term profound gastric acid suppression, cost and effect on quality of life remain to be resolved. | DOI: | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.3109/00365529609094752 | Link to associated publication: | Click here for full text options | PubMed URL: | 8898438 [http://www.ncbi.nlm.nih.gov/pubmed/?term=8898438] | ISSN: | 0085-5928 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/26854 | Type: | Conference Paper | Subjects: | *reflux esophagitis/di [Diagnosis] *reflux esophagitis/dt [Drug Therapy] *reflux esophagitis/et [Etiology] stomach acid secretion stomach cancer *cisapride/dt [Drug Therapy] *histamine H2 receptor antagonist/dt [Drug Therapy] lansoprazole/dt [Drug Therapy] omeprazole/dt [Drug Therapy] *proton pump inhibitor/dt [Drug Therapy] *sucralfate/dt [Drug Therapy] *reflux esophagitis/su [Surgery] antireflux operation conference paper endoscopy esophagus pH *gastroesophageal reflux/di [Diagnosis] *gastroesophageal reflux/dt [Drug Therapy] *gastroesophageal reflux/et [Etiology] *gastroesophageal reflux/su [Surgery] Helicobacter pylori human internal medicine lower esophagus sphincter maintenance therapy priority journal *gastroesophageal reflux / *diagnosis / *drug therapy / *etiology / *surgery esophagus pH endoscopy conference paper Helicobacter pylori esophagus ph helicobacter pylori antireflux operation human internal medicine lower esophagus sphincter maintenance therapy priority journal *reflux esophagitis / *diagnosis / *drug therapy / *etiology / *surgery stomach acid secretion stomach cancer |
Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.